Showing results (241-250 of 260) with videos related to

Sort By:
Pageof 26
Oncotarget|May 27, 2017
NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemiaAnne-Sophie Chretien, Cyril Fauriat, Florence Orlanducci, et al.
Cancer Research Communications|October 23, 2024
ETx-22, a Novel Nectin-4-Directed Antibody-Drug Conjugate, Demonstrates Safety and Potent Antitumor Activity in Low-Nectin-4-Expressing TumorsMarc Lopez, Emerence Crompot, Emmanuelle Josselin, et al.
Cancer Research|October 10, 2014
ITPR1 protects renal cancer cells against natural killer cells by inducing autophagyYosra Messai, Muhammad Zaeem Noman, Meriem Hasmim, et al.
Oncoimmunology|September 14, 2016
Immunomodulatory antibodies for the treatment of lymphoma: Report on the CALYM WorkshopRoch Houot, Philippe Gaulard, Robert Schreiber, et al.
Cancer Research|June 28, 2023
CD25high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast CancerStéphane Fattori, Aude Le Roy, Jemila Houacine, et al.
Cancer Immunology Research|July 8, 2025
Vγ9Vδ2 T Cells Express an Antitumor Profile Associated with Anti-PD-(L)1 Responses and Activation Defects Restored by Anti-BTN3A in Triple-Negative Breast CancerStéphane Fattori, Laurent Gorvel, Marie-Sarah Rouvière, et al.
Science Translational Medicine|October 20, 2021
Development of ICT01, a first-in-class, anti-BTN3A antibody for activating Vγ9Vδ2 T cell-mediated antitumor immune responseAude De Gassart, Kieu-Suong Le, Patrick Brune, et al.
Nature Communications|June 30, 2022
Endowing universal CAR T-cell with immune-evasive properties using TALEN-gene editingSumin Jo, Shipra Das, Alan Williams, et al.
BMC Cancer|May 13, 2023
Low plasma PD-L1 levels, early tumor onset and absence of peritoneal carcinomatosis improve prognosis of women with advanced high-grade serous ovarian cancerDaniele Fanale, Chiara Brando, Lidia Rita Corsini, et al.
Blood Advances|May 24, 2024
Low frequency of Vγ9Vδ2 T cells predicts poor survival in newly diagnosed acute myeloid leukemiaAnne-Charlotte Le Floch, Florence Orlanducci, Marie-Christine Béné, et al.
Pageof 26